Definitive Contract 75D30120C09834

Award Date 9/28/20
Potential Completion Date 12/31/22
Potential Value $570K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wellington, CO 80549, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced...
This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...
This is a $1,103,280.60 Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Geisinger Clinic, a non-profit healthcare organization, for the "Surveillance Based Lyme Disease Network (SUBLYME)" project. The contract does not have a set-aside designation. Geisinger Clinic will provide surveillance and research services related to Lyme disease, leveraging its expertise in areas such as epidemiology, implementation science, and community...
This is a firm-fixed-price delivery order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Alpha Genesis Inc., a for-profit subchapter S corporation headquartered in Yemassee, South Carolina. The $450,000.00 contract is for per diem and testing costs related to maintaining a specific pathogen-free (SPF) nonhuman primate colony in support of a Statement of Work. The award does not have a set-aside designation, indicating Alpha Genesis competes across the...
The Centers for Disease Control and Prevention awarded a $98,669.98 firm fixed price purchase order to Colorado State University under a sole source solicitation. The contract is for tick surveillance bioinformatics pipeline development to obtain a bioinformatics pipeline to support CDC's tick-borne disease surveillance efforts. Performance will take place in Fort Collins, Colorado over a three year period concluding in May 2023. No subcontractors or set aside designations were identified....
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation. The contract, valued at $100,000.00, is for tick management, tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide (pesticide for killing ticks) application methods. The contract has an ultimate completion date of August 20, 2018 and was awarded on August 21, 2017. The award was not...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $106,950 firm-fixed-price purchase order to Marshfield Clinic, Inc., a non-profit healthcare organization, to use electronic health records to identify and describe Lyme disease diagnoses. This contract, which does not have a set-aside designation, was awarded on September 14, 2020 with a completion date of September 30, 2021. Marshfield Clinic is a prime contractor that provides the CDC with...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for a Feasibility Tick Disease Management effort. The $230,000.00 contract, which has a completion date of September 10, 2022, is focused on tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods. The contract does not have...
This federal contract award was made by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Tick Box Technology Corporation, a manufacturer of goods, for the purchase of Tick Control System Master Cases - Bait Boxes. The contract, valued at $112,226.00, is a Firm Fixed Price purchase order with a completion date of June 30, 2019. The original solicitation was a pre-solicitation notice that cited the statutory authority of 10 U.S.C. 2304(c)(1)...
This is a $1,315,748.75 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Banfieldbio Inc., a for-profit technology research company located in Woodinville, Washington. The contract is for research and development services related to developing novel pest management solutions and innovative technologies for pest control, with a focus on areas such as insect and tick management. The contract is not set-aside and has a period of...

Genesis Laboratories, Inc. was awarded a $570,428.55 firm fixed price definitive contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide a mineral lick to systematically control black-legged ticks and reduce Lyme disease incidence among white-tailed deer populations in Wellington, Colorado. As a subchapter S corporation, Genesis Laboratories will supply mineral licks intended to deliver fipronil-laced oral bait to white-tailed deer, in support of the CDC's vector-borne disease program goal of controlling immature Ixodes scapularis ticks. The contract completion date is December 31, 2022. No set-aside designation was associated with this award to the prime contractor Genesis Laboratories.

Generated 2/1/24, 10:24 AM